标题
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
作者
关键词
-
出版物
Lancet Respiratory Medicine
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-19
DOI
10.1016/s2213-2600(21)00103-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
- (2021) Viviane C Veiga et al. BMJ-British Medical Journal
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
- (2020) Michael E O'Brien et al. THORAX
- Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials
- (2020) Pratik Sinha et al. Lancet Respiratory Medicine
- COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
- (2020) Qingxian Cai et al. ALLERGY
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
- (2020) Tao Liu et al. EMBO Molecular Medicine
- Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
- (2020) Daniel E. Leisman et al. INTENSIVE CARE MEDICINE
- Management of COVID-19 Respiratory Distress
- (2020) John J. Marini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19
- (2020) Yong Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy
- (2020) Oliver J. McElvaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- COVID-19: Clean up on IL-6
- (2020) Tanner L Hedrick et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Tocilizumab for treatment of mechanically ventilated patients with COVID-19
- (2020) Emily C Somers et al. CLINICAL INFECTIOUS DISEASES
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Is a “Cytokine Storm” Relevant to COVID-19?
- (2020) Pratik Sinha et al. JAMA Internal Medicine
- Caution about early intubation and mechanical ventilation in COVID-19
- (2020) Martin J. Tobin et al. Annals of Intensive Care
- Severe immunosuppression and not a cytokine storm characterize COVID-19 infections
- (2020) Kenneth E. Remy et al. JCI Insight
- Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
- (2020) Jennifer G. Wilson et al. JCI Insight
- Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
- (2020) Bicheng Zhang et al. Frontiers in Molecular Biosciences
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
- (2020) Andrea Rubbert-Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
- (2020) Carl A. Pierce et al. Science Translational Medicine
- Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia
- (2020) Jonathan B. Parr JAMA Internal Medicine
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study
- (2020) Pratik Sinha et al. Lancet Respiratory Medicine
- Acute respiratory distress syndrome
- (2019) Michael A. Matthay et al. Nature Reviews Disease Primers
- Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia
- (2018) Cormac McCarthy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study
- (2018) Pratik Sinha et al. INTENSIVE CARE MEDICINE
- Acute respiratory distress syndrome (ARDS) phenotyping
- (2018) M. Shankar-Hari et al. INTENSIVE CARE MEDICINE
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Interleukin (IL-6) Immunotherapy
- (2017) Toshio Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
- (2017) Steffen Riethmueller et al. PLOS BIOLOGY
- Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome*
- (2016) Jehan W. Alladina et al. CRITICAL CARE MEDICINE
- IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice
- (2016) Juri Bergmann et al. HEPATOLOGY
- HIF1α and metabolic reprogramming in inflammation
- (2016) Sarah E. Corcoran et al. JOURNAL OF CLINICAL INVESTIGATION
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2016) Mark C. Genovese et al. Arthritis & Rheumatology
- A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy
- (2016) Joel M. Kremer et al. Arthritis & Rheumatology
- Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis
- (2016) Gustav Nilsonne et al. PLoS One
- Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra
- (2015) Leo A B Joosten et al. ANNALS OF THE RHEUMATIC DISEASES
- The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4Neutrophil Signaling
- (2015) Ciara A. O’Dwyer et al. JOURNAL OF IMMUNOLOGY
- The Circulating Proteinase Inhibitor -1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity
- (2014) D. A. Bergin et al. Science Translational Medicine
- Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials
- (2014) Carolyn S Calfee et al. Lancet Respiratory Medicine
- The Warburg effect then and now: From cancer to inflammatory diseases
- (2013) Eva M. Palsson-McDermott et al. BIOESSAYS
- Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
- (2013) L. Van Rompaey et al. JOURNAL OF IMMUNOLOGY
- Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples
- (2013) Genoveva C.E. Keustermans et al. METHODS
- Therapeutic modulators of STAT signalling for human diseases
- (2013) Gabriella Miklossy et al. NATURE REVIEWS DRUG DISCOVERY
- Prone Positioning in Severe Acute Respiratory Distress Syndrome
- (2013) Claude Guérin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory and immunomodulatory properties of 1-antitrypsin without inhibition of elastase
- (2013) D. Jonigk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-6: from its discovery to clinical applications
- (2010) T. Kishimoto INTERNATIONAL IMMUNOLOGY
- α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
- (2010) David A. Bergin et al. JOURNAL OF CLINICAL INVESTIGATION
- A Case of Multicentric Castleman's Disease Having Lung Lesion Successfully Treated with Humanized Anti-interleukin-6 Receptor Antibody, Tocilizumab
- (2010) Tomoaki Higuchi et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Failed interleukin-6 signal transduction in murine sepsis: Attenuation of hepatic glycoprotein 130 phosphorylation
- (2009) Arnoley S. Abcejo et al. CRITICAL CARE MEDICINE
- α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
- (2009) Gregory B. Pott et al. JOURNAL OF LEUKOCYTE BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search